Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jun 3;16(6):e0252539. doi: 10.1371/journal.pone.0252539

Experiences with sexual orientation and gender identity conversion therapy practices among sexual minority men in Canada, 2019–2020

Travis Salway 1,2,3,4,*, Stephen Juwono 1,4,5, Ben Klassen 4, Olivier Ferlatte 4,6,7, Aidan Ablona 2,4, Harlan Pruden 2,4, Jeffrey Morgan 4,8, Michael Kwag 4, Kiffer Card 4,9, Rod Knight 4,10, Nathan J Lachowsky 4,9
Editor: Xiaozhao Yousef Yang11
PMCID: PMC8174694  PMID: 34081740

Abstract

Background

“Conversion therapy” practices (CTP) are organized and sustained efforts to avoid the adoption of non-heterosexual sexual orientations and/or of gender identities not assigned at birth. Few data are available to inform the contemporary prevalence of CTP. The aim of this study is to quantify the prevalence of CTP among Canadian sexual and gender minority men, including details regarding the setting, age of initiation, and duration of CTP exposure.

Methods

Sexual and gender minority men, including transmen and non-binary individuals, aged ≥ 15, living in Canada were recruited via social media and networking applications and websites, November 2019—February 2020. Participants provided demographic data and detailed information about their experiences with CTP.

Results

21% of respondents (N = 9,214) indicated that they or any person with authority (e.g., parent, caregiver) ever tried to change their sexual orientation or gender identity, and 10% had experienced CTP. CTP experience was highest among non-binary (20%) and transgender respondents (19%), those aged 15–19 years (13%), immigrants (15%), and racial/ethnic minorities (11–22%, with variability by identity). Among the n = 910 participants who experienced CTP, most experienced CTP in religious/faith-based settings (67%) or licensed healthcare provider offices (20%). 72% of those who experienced CTP first attended before the age of 20 years, 24% attended for one year or longer, and 31% attended more than five sessions.

Interpretation

CTP remains prevalent in Canada and is most prevalent among younger cohorts, transgender people, immigrants, and racial/ethnic minorities. Legislation, policy, and education are needed that target both religious and healthcare settings.

Introduction

“Conversion therapy” practices (CTP) are organized and sustained efforts to avoid the adoption or expression of lesbian, gay, bisexual, or queer (LGBQ) sexual orientations, gender identities not assigned at birth, and/or non-conforming gender expressions [1, 2]. In the case of CTP targeting sexual orientation, these practices often borrow pseudo-scientific behavioural interventions to supress or deter same-sex/gender attraction (including sex with members of the same sex/gender) [3]. CTP targeting gender identity and expression likewise include so-called psychotherapeutic attempts to “discourage or delay the adoption of gender identities not assigned at birth, as well as non-conforming gender expressions” [4, 5]. Research evidence has clearly established multiple harms associated with CTP, including feelings of shame, anxiety, depression, problematic substance use, suicide ideation, and/or suicide attempts [611].

CTP are undergirded by a broader set of practices known as sexual orientation and gender identity or expression change efforts (SOGIECE), which include CTP, as well as less-delineated cissexist and heterosexist stressors experienced by sexual minorities (i.e., those who experience non-heterosexual attraction, behaviours, or identities) and gender minorities (i.e., those who experience gender identities that differ from sex assigned at birth and those who have non-conforming gender expressions) [12]. For further clarity, while CTP tend to have a defined structure—a set number of individual- and/or group-focused sessions—SOGIECE include subtler but often more pervasive attempts to pursuade and affirm rigid expectations of a cisgender and heterosexual expressions and identities [12]. SOGIECE take a broad variety of forms and are context-specific. For example, in some cases, these change efforts manifest as conversations between a religious leader and believer, in which the leader compels the believer to adhere to heteronormative or cisnormative behaviors. In other cases, institutions and practices that are not typically regarded as CTP nonetheless constitute SOGIECE. For example, residential schools—used by Canadian and US governments and Christian churches to indoctrinate Indigenous children with European ways of living—were also used to enforce European binary notions of gender, by imposing particular styles of dress, hair, and behavior consistent with those expected of boys and girls, thereby erasing Two-Spirit traditions (Two-Spirit is a contemporary umbrella term and organizing tool to facilitate Indigenous Peoples’ connections with Nation-specific expressions and roles of gender and sexual diversity) [13, 14].

Data regarding the prevalence and nature of contemporary CTP and SOGIECE are scarce. Recent surveys in the US have estimated that 4–18% of sexual and gender minority people have experienced CTP at some point in their lifetime—with estimates varying based on age of participants, other sample characteristics, and definition of CTP used [10, 1518]. To date, two similar non-probabilistic venue/network-sampled national surveys have been conducted in Canada, one in 2011–12 focused on sexual minority men (Sex Now 2011–12, N = 8388, median age 40–49 years) [8] and one in 2019 focused on gender minorities (Trans PULSE 2019, N = 2033, median age 25–34 years) [19]. Sex Now 2011–12 defined CTP as “sexual repair/reorientation counseling” and found that 3.5% of men surveyed had experienced this form of CTP during their lifetime [8]. Trans PULSE 2019 defined CTP as “counselling or programs to try to make your gender match with your sex assigned at birth” and found that 11% of those surveyed reported a lifetime experience of CTP [19]. While these data give a sense of the scope of contemporary CTP, numerous gaps in knowledge remain, notably the settings in which CTP occurs, age at initiation of CTP, and duration of CTP. Empirical data regarding these CTP parameters can help to inform and refine legislative, policy, and educational approaches to prevent CTP (including bans and educational campaigns explaining the dangers of CTP), by identifying where and when to target preventive efforts [12, 20].

As international policymakers and legislators are increasingly acknowledging CTP as a threat to the health and well-being of sexual and gender minority people [2, 21], additional, fulsome, and contemporary characterizations of the prevalence and nature of CTP are urgently needed. As of November 18, 2020, four Canadian provinces and territories (Ontario, Nova Scotia, Prince Edward Island, Yukon) and numerous Canadian municipalities (including Vancouver, Calgary, and Edmonton) have enacted a patchwork of legislative CTP bans that range from prohibiting CTP for minors and outlawing healthcare providers from offering CTP, with other proposed legislation (e.g., in Quebec) emerging rapidly [22]. Enforcement of provincial and municipal bans has been limited, likely owing to problems with the narrow definition of CTP used in these bans and the lack of transparency on the part of CT practitioners with regard to what their service intends to achieve [2, 23]. On October 1, 2020, the Canadian federal government tabled Bill C-6, An Act to Amend the Criminal Code (conversion therapy), which is expected to be reviewed in Parliamentary committee later this year [24]. In this context, we collected data from a large national sample of sexual and gender minority men (i.e. men identifying as gay, bisexual, trans, and queer), and Two-Spirit and non-binary people, in 2019–2020, and used this survey to assess CTP and SOGIECE experiences and inform ongoing proposals for legislation and policy, including required amendments to Bill C-6. Our primary objective was to estimate the lifetime prevalence of CTP experiences among sexual minority men in Canada sampled in 2019–2020. Secondary objectives were to: a) estimate the prevalence of CTP and SOGIECE experience across sociodemographic subgroups of sexual minority men; b) describe settings, age at initiation, and duration of CTP; and c) identify health disparities among individuals who experienced CTP.

Methods

Participants

Sex Now is a serial cross-sectional survey of gay, bisexual, trans, and queer men and Two-Spirit and non-binary people in Canada conducted by the Community-Based Research Centre (CBRC). Participants are sampled from general social media platforms (Facebook, Twitter, etc.), geolocating sexual/social networking apps targeted to sexual and gender minority men (Squirt, Scruff, Grindr, etc.), CBRC’s newsletter membership, other community agencies’ newsletter memberships and word-of-mouth. The questionnaire is offered in Canada’s two official languages, English and French, and includes a broad set of questions that correspond to community-identified health and social priorities for sexual minority men in Canada. Because there is no defined sampling frame for sexual minority men [25], and because we cannot track how many unique individuals have seen recruitment materials for Sex Now across the multiple sampling platforms, a response rate cannot be calculated. The Sex Now 2019–20 study protocol was approved by the University of Victoria Research Ethics Board. Written informed consent was documented at the start of the survey; consent from parents or guardians was not sought for participants who were minors, consistent with review/approval of the Research Ethics Board.

Data collection for the 2019–20 Sex Now survey occurred between November 4, 2019 and February 6, 2020. In order to be eligible to participate in the survey, participants had to: 1) self-identify as men (inclusive of trans men), non-binary (regardless of sex assigned at birth), or Two-Spirit; 2) identify as gay, bisexual, queer, or another non-heterosexual identity and/or have reported having had sex with a man (cis or trans) in the last 5 years; 3) be 15 years of age or older; 4) be living in Canada; 5) be able to provide informed consent and complete the questionnaire in either French or English, and; 6) not have already participated in the study. Written informed consent was documented at the start of the survey; consent from parents or guardians was not sought for participants who were minors. A total of N = 14,364 individuals entered the study, of which 121 did not consent to participate, and a further 1,587 people were ineligible. In total, N = 7,237 completed the entire survey (i.e., provided a response to the last question). For the present study, we subsetted the dataset to those who answered the primary outcome question regarding CTP experience (N = 9,214).

Measures

The primary outcome for this study was derived from the question, “have you ever been exposed to any of the following conversion efforts (check all that apply)? Conversion efforts by: licensed healthcare professional (psychologist, psychiatrist, doctor), unlicensed counselor, camp, faith-based organization focused on conversion therapy, individual religious leader (i.e., not through a formal organization), and/or another religious individual.” We defined conversion efforts as “attempts to change sexual orientation or gender identity [including] more organized activities (such as counseling or faith-based rituals) that are sometimes referred to as ‘conversion therapy.’” Hereafter, we refer to this outcome as CTP exposure.

As a secondary outcome, we asked participants about their experiences with SOGIECE, specifically, “have you or any person with authority (parent, caregiver, counselor, community leader, etc.) ever tried to change your sexual orientation or gender identity?” Hereafter, we refer to this outcome as SOGIECE exposure.

We considered the following social-demographic variables as potentially important modifiers of exposure to CTP and SOGIECE (secondary objective a), based on previous literature [7, 8, 11, 17]: sexual identity (“how do you identify sexually?”); gender identity (non-binary, male, other); transgender status (“do you have trans experience (i.e., your gender is different than the sex you were assigned at birth)?”); age; being ‘out’ (told others) about one’s sexual identity; race/ethnicity; Two-Spirit status (among Indigenous participants); formal educational attainment; personal annual income; area of residence (urban, suburban, rural); immigration status (immigrant, Canadian-born); and province/territory of residence.

Among those exposed to SOGIECE, we asked whether it was their sexual orientation, gender identity, or both, which were targeted by SOGIECE. Among those exposed to CTP, we asked about the following details (secondary objective b): setting/source of CTP (licensed healthcare professional, unlicensed counselor, camp, faith-based organization, individual religious leader, and/or another religious individual); age at first initiation of CTP; lifetime duration of CTP (<1 month, 1 month– 1 year, or >1 year); and lifetime number of times attending CTP (1, 2–5, 6+).

Finally, we compared psychosocial health outcomes and access to social and professional supports between those exposed to CTP or SOGIECE and those not exposed to either: feeling isolated some or all of the time (“How often do you feel isolated from others?”); left out some or all of the time (“How often do you feel left out?”); any binge alcohol use, past 6 months (“5+ drinks within 2 hours” at least once in the past 6 months); any opiate, hallucinogen, benzodiazepine, or stimulant use (hereafter “other substance use”), past 6 months (included substances: ketamine, ecstasy, crystal methamphetamines, crack, cocaine, heroin, other prescription opioids, fentanyl, γ-Hydroxybutyric acid (“GHB”), tranquilizers or benzodiazapines, or psychedelics, e.g., lysergic acid diethylamide, mescaline, mushrooms); current involvement with gay, bisexual, and/or queer (GBQ) community (“What are you CURRENTLY involved in? (check all that apply) [Gay activism, organization, or cultural activities]”); connection to GBQ community (“How connected do you feel to the following: [Gay, bi and queer men’s communities?]”); and mental health service access (“In the PAST YEAR, which of the following resources have you gone to? (check all that apply) [Registered and/or peer counsellor, Indigenous elder and/or knowledge keeper, psychiatrist, psychologist]”).

Analyses

For our primary objective, we estimated the proportion of Sex Now participants who reported lifetime exposure to CTP, including a 95% confidence interval (CI), offered as an estimate of precision, despite not meeting the assumption of randomness in this sample (i.e., CIs should be interpreted with caution). For secondary objectives, we similarly estimated proportions with 95% CI of those exposed to CTP and SOGIECE, including by socially-defined sub-groups. Between-group comparisons were made by estimating relative risks (RR) of CTP/SOGIECE exposure, with 95% CI calculated using exact methods with the R package Epi. RR 95% CI that exclude 1 were interpreted as statistically significant relative differences. Duration and frequency of CTP experiences were compared across sexual orientation and gender identity sub-groups. Missing, poor data quality (e.g., conflicting answers), and “prefer not to answer” responses were removed from analyses, when applicable. Because we were interested in associations between socio-demographic characteristics and CTP/SOGIECE exposure irrespective of correlations between socio-demographic variables, we focused our interpretation on bivariate (“crude”) analyses. Multivariable regression models were additionally used as sensitivity analyses, specifically to examine whether associations identified in bivariate analyses persisted after adjustment for covariates. We used Zou’s method of Poisson regression with robust variance estimation, executed with the R package geepack, to calculate adjusted relative risks (aRR), with 95% CI [26]. All analyses were conducted in R Version 3.6.3.

Results

Lifetime prevalence of CTP exposure

9.9% (95% CI 9.3, 10.5) of participants sampled in Sex Now 2019–20 reported lifetime exposure to CTP. CTP exposure was greater among those who identified as gay (10.4%), pansexual (13.8%), or queer (15.6%), and lesser among those who identified as bisexual (8.2%) or heteroflexible (7.7%) (Table 1). CTP exposure was also greater among non-binary participants (20.0%), transgender participants (19.1%), immigrants (14.6%), younger participants (e.g., 13.2% among those <20 years of age), those who are ‘out’ about their sexuality (10.6%), and those earning <$30,000 per year (13.6%). Lifetime prevalence of CTP exposure was lowest among white participants (8.7%); higher among South Asian (13.9%), Indigenous (13.5%), Southeast Asian (12.7%), and East Asian (11.0%) participants; and highest among Arab (22.1%), Caribbean (21.1%), Latin American (20.8%), African (18.5), and Black (18.0%) participants. CTP prevalence ranged 8.1%-14.3% across all provinces and territories, except for Quebec (6.8%) and Yukon (4.2%), though the small sample size for Yukon did not allow for precision in this estimate.

Table 1. Lifetime prevalence of exposure to conversion therapy among sexual and gender minority Canadian men, by sociodemographic subgroups, 2019.

Variable n (%) in SN2019a (n = 9214) Exposure to Conversion Therapyb, n (%) % Exposed to Conversion Therapyc (95% CI) RR (95% CI)
Yes (n = 910) No (n = 8304)
Sexual identityd
    Gay 6984 (76.0) 723 (79.7) 6261 (75.6) 10.4 (9.7–11.1) 1.24 (1.06–1.45)
    Bisexual 2035 (22.1) 166 (18.3) 1869 (22.6) 8.2 (7.0–9.5) 0.79 (0.67–0.93)
    Asexual 153 (1.7) 20 (2.2) 133 (1.6) 13.1 (8.4–19.7) 1.33 (0.88–2.01)
    Pansexual 694 (7.5) 96 (10.6) 598 (7.2) 13.8 (11.4–16.7) 1.45 (1.19–1.77)
    Heteroflexible 220 (2.4) 17 (1.9) 203 (2.5) 7.7 (4.7–12.3) 0.78 (0.49–1.24)
    Queer 1397 (15.2) 218 (24.0) 1179 (14.2) 15.6 (13.8–17.6) 1.77 (1.53–2.03)
    Other 134 (1.5) 16 (1.8) 118 (1.4) 11.9 (7.2–18.9) 1.22 (0.77–1.94)
Gender identity
    Non-binary 290 (3.1) 58 (6.4) 232 (2.8) 20.0 (15.6–25.2) 2.11 (1.66–2.68)
    Other 70 (0.8) 12 (1.3) 58 (0.7) 17.1 (9.5–28.4) 1.81 (1.08–3.04)
    Male 8852 (96.1) 839 (92.3) 8013 (96.5) 9.5 (8.9–10.1) Referent
Transgender status
    Transgender 791 (8.7) 151 (17.0) 640 (7.8) 19.1 (16.4–22.0) 2.15 (1.83–2.52)
    Cisgender 8313 (91.3) 739 (83.0) 7574 (92.2) 8.9 (8.3–9.5) Referent
Two-Spirit status (of Indigenous participants)
    Two-Spirit 170 (37.3) 29 (46.8) 141 (35.8) 17.1 (11.9–23.7) 1.48 (0.93–2.35)
    Not Two-Spirit 286 (62.7) 33 (53.2) 253 (64.2) 11.5 (8.2–16.0) Referent
Age (at time of survey)
    < 20 372 (4.0) 49 (5.4) 323 (3.9) 13.2 (10.0–17.1) 1.44 (1.03–2.03)
    20–29 2717 (29.5) 279 (30.7) 2438 (29.4) 10.3 (9.2–11.5) 1.13 (0.88–1.43)
    30–39 2362 (25.6) 237 (26.0) 2125 (25.6) 10.0 (8.9–11.3) 1.10 (0.86–1.41)
    40–49 1380 (15.0) 138 (15.2) 1242 (15.0) 10.0 (8.5–11.7) 1.10 (0.84–1.43)
    50–59 1561 (16.9) 132 (14.5) 1429 (17.2) 8.5 (7.1–10.0) 0.93 (0.71–1.21)
    60+ 822 (8.9) 75 (8.2) 747 (9.0) 9.1 (7.3–11.4) Referent
“Out” about sexuality
    Out 6801 (74.0) 720 (79.5) 6081 (73.4) 10.6 (9.9–11.3) 1.36 (1.16–1.59)
    Not out 2387 (26.0) 186 (20.5) 2201 (26.6) 7.8 (6.8–9.0) Referent
Race/Ethnicityd
    African 81 (0.9) 15 (1.7) 66 (0.8) 18.5 (11.1–29.0) 1.89 (1.19–2.99)
    Arab 163 (1.8) 36 (4.0) 127 (1.5) 22.1 (16.1–29.4) 2.29 (1.70–3.07)
    Asian 290 (3.2) 32 (3.5) 258 (3.1) 11.0 (7.8–15.4) 1.12 (0.80–1.56)
    Black 172 (1.9) 31 (3.4) 141 (1.7) 18.0 (12.7–24.8) 1.85 (1.34–2.56)
    Caribbean 175 (1.9) 37 (4.1) 138 (1.7) 21.1 (15.5–28.1) 2.19 (1.63–2.93)
    Indigenous 495 (5.4) 67 (7.4) 428 (5.2) 13.5 (10.7–16.9) 1.40 (1.11–1.76)
    Latin-American 336 (3.7) 70 (7.8) 266 (3.2) 20.8 (16.7–25.7) 2.20 (1.77–2.74)
    South Asian 202 (2.2) 28 (3.1) 174 (2.1) 13.9 (9.6–19.6) 1.42 (1.00–2.01)
    Southeast Asian 181 (2.0) 23 (2.5) 158 (1.9) 12.7 (8.4–18.7) 1.29 (0.88–1.90)
    White 7687 (84.1) 671 (74.3) 7016 (85.2) 8.7 (8.1–9.4) 0.55 (0.48–0.63)
Educational attainment
    < College/university degree 2053 (23.2) 213 (25.1) 1840 (23.0) 10.4 (9.1–11.8) 1.11 (0.96–1.28)
    College/university degree 6778 (76.8) 635 (74.9) 6143 (77.0) 9.4 (8.7–10.1) Referent
Personal income, CAD
    < $30,000 2743 (33.8) 374 (47.3) 2369 (32.3) 13.6 (12.4–15.0) 2.01 (1.70–2.37)
    $30,000 to $59,999 2507 (30.9) 221 (28.0) 2286 (31.2) 8.8 (7.7–10.0) 1.30 (1.08–1.56)
    ≥ $60,000 2874 (35.4) 195 (24.7) 2679 (36.5) 6.8 (5.9–7.8) Referent
Area of residence
    Rural 423 (4.8) 45 (5.3) 378 (4.7) 10.6 (7.9–14.1) 1.15 (0.86–1.53)
    Suburban 2303 (26.0) 233 (27.5) 2070 (25.8) 10.1 (8.9–11.4) 1.09 (0.95–1.26)
    Urban 6155 (69.3) 569 (67.2) 5586 (69.5) 9.2 (8.5–10.0) Referent
Immigration status
    Immigrant 1499 (16.4) 219 (24.3) 1280 (15.5) 14.6 (12.9–16.5) 1.64 (1.43–1.89)
    Canadian-born 7662 (83.6) 681 (75.7) 6981 (84.5) 8.9 (8.3–9.6) Referent
Province/Territory
    British Columbia 1642 (17.8) 181 (19.9) 1461 (17.6) 11.0 (9.6–12.7) Referent
    Alberta 1383 (15.0) 150 (16.5) 1233 (14.8) 10.8 (9.3–12.6) 0.98 (0.80–1.21)
    Saskatchewan 241 (2.6) 22 (2.4) 219 (2.6) 9.1 (5.9–13.7) 0.83 (0.54–1.26)
    Manitoba 286 (3.1) 41 (4.5) 245 (3.0) 14.3 (10.6–19.1) 1.30 (0.95–1.78)
    Ontario 2805 (30.4) 302 (33.2) 2503 (30.1) 10.8 (9.7–12.0) 0.98 (0.82–1.16)
    Quebec 2031 (22.0) 138 (15.2) 1893 (22.8) 6.8 (5.8–8.0) 0.62 (0.50–0.76)
    Newfoundland & Labrador 153 (1.7) 18 (2.0) 135 (1.6) 11.8 (7.3–18.2) 1.07 (0.68–1.68)
    New Brunswick 163 (1.8) 15 (1.6) 148 (1.8) 9.2 (5.4–15.0) 0.83 (0.51–1.38)
    Nova Scotia 422 (4.6) 34 (3.7) 388 (4.7) 8.1 (5.7–11.1) 0.73 (0.51–1.04)
    Prince Edward Island 45 (0.5) 6 (0.7) 39 (0.5) 13.3 (5.5–27.5) 1.21 (0.57–2.58)
    Yukon 24 (0.3) 1 (0.1) 23 (0.3) 4.2 (0.2–23.1) 0.38 (0.06–2.59)
    Northwest Territories 8 (0.1) 1 (0.1) 7 (0.1) 12.5 (0.01–53.3) 1.13 (0.18–7.13)
    Nunavut 11 (0.1) 1 (0.1) 10 (0.1) 9.1 (0.5–42.9) 0.82 (0.13–5.37)

Note: N = 9,214; CI, confidence interval; RR, relative risk comparing prevalence of conversion therapy exposure to that of referent group; SN2019, Sex Now 2019.

a Missing, poor data quality, and “prefer not to answer” responses removed when applicable

b Percentage calculated using column total as denominator.

c Percentage calculated using row total as denominator.

d Responses allowed multiple-answers, overlap in responses.

Lifetime prevalence in SOGIECE exposure

20.6% (95% CI 19.8, 21.4) of Sex Now 2019–20 participants reported lifetime exposure to SOGIECE. Differences in SOGIECE exposure by sociodemographic subgroups were similar in direction and statistical significance as those observed for CTP, with the following exceptions (Table 2). Asexual participants (35.1%) and those without a college/university degree (23.4%) reported greater SOGIECE exposure than relevant comparator groups, while those living in Quebec (14.3%) and Saskatchewan (17.6%) reported lesser SOGIECE exposure than those living in British Columbia (23.7%).

Table 2. Lifetime prevalence of exposure to Sexual Orientation and Gender Identity Change Efforts (SOGIECE) among sexual and gender minority Canadian men, by sociodemographic subgroups, 2019.

Variable n (%) in SN2019a (n = 9152) Exposure to SOGIECEb, n (%) % Exposed to SOGIECEc (95% CI) RR (95% CI)
Yes (n = 1884) No (n = 7268)
Sexual identityd
    Gay 6952 (76.0) 1449 (76.9) 5503 (75.8) 20.8 (19.9–21.8) 1.05 (0.95–1.15)
    Bisexual 2016 (22.1) 368 (19.5) 1648 (22.7) 18.3 (16.6–20.0) 0.86 (0.77–0.95)
    Asexual 151 (1.7) 53 (2.8) 98 (1.4) 35.1 (27.6–43.3) 1.72 (1.38–2.15)
    Pansexual 688 (7.5) 224 (11.9) 464 (6.4) 32.6 (29.1–36.2) 1.66 (1.48–1.86)
    Heteroflexible 217 (2.4) 29 (1.5) 188 (2.6) 13.4 (9.3–18.8) 0.64 (0.46–0.90)
    Queer 1387 (15.2) 498 (26.4) 889 (12.2) 35.9 (33.4–38.5) 2.01 (1.85–2.19)
    Other 132 (1.5) 38 (2.0) 94 (1.3) 28.8 (21.4–37.4) 1.41 (1.08–1.85)
Gender identity
    Non-binary 288 (3.1) 139 (7.4) 149 (2.1) 48.3 (42.4–54.2) 2.47 (2.17–2.80)
    Other 70 (0.8) 26 (1.4) 44 (0.6) 37.1 (26.1–49.6) 1.90 (1.40–2.58)
    Male 8792 (96.1) 1719 (91.2) 7073 (97.3) 19.6 (18.7–20.4) Referent
Transgender status
    Transgender 778 (8.6) 389 (21.0) 389 (5.4) 50.0 (46.5–53.5) 2.83 (2.60–3.08)
    Cisgender 8269 (91.4) 1460 (79.0) 6809 (94.6) 17.7 (16.8–18.5) Referent
Two-Spirit status (of Indigenous participants)
    Two-Spirit 169 (37.1) 45 (36.3) 124 (37.5) 26.5 (20.1–33.9) 0.96 (0.71–1.32)
    Not Two-Spirit 286 (62.9) 79 (63.7) 207 (62.5) 27.6 (22.6–33.3) Referent
Age (at time of survey)
    < 20 368 (4.0) 134 (7.1) 234 (3.2) 36.4 (31.5–41.6) 3.03 (2.41–3.81)
    20–29 2695 (29.4) 691 (36.7) 2004 (27.6) 25.6 (24.0–27.3) 2.13 (1.75–2.60)
    30–39 2346 (25.6) 469 (24.9) 1877 (25.8) 20.0 (18.4–21.7) 1.66 (1.36–2.04)
    40–49 1371 (15.0) 255 (13.5) 1116 (15.4) 18.6 (16.6–20.8) 1.55 (1.25–1.92)
    50–59 1557 (17.0) 237 (12.6) 1320 (18.2) 15.2 (13.5–17.1) 1.27 (1.02–1.58)
    60+ 815 (8.9) 98 (5.2) 717 (9.9) 12.0 (9.9–14.5) Referent
“Out” about sexuality
    Out 6775 (74.1) 1520 (80.7) 5255 (72.4) 22.4 (21.5–23.5) 1.46 (1.32–1.62)
    Not out 2366 (25.9) 363 (19.3) 2003 (27.6) 15.3 (13.9–16.9) Referent
Race/Ethnicityd
    African 81 (0.9) 28 (1.5) 53 (0.7) 34.6 (24.6–46.0) 1.69 (1.25–2.29)
    Arab 163 (1.8) 62 (3.3) 101 (1.4) 38.0 (30.7–46.0) 1.88 (1.54–2.29)
    Asian 288 (3.2) 93 (5.0) 195 (2.7) 32.3 (27.0–38.1) 1.60 (1.35–1.90)
    Black 170 (1.9) 56 (3.0) 114 (1.6) 32.9 (26.0–40.6) 1.62 (1.30–2.01)
    Caribbean 171 (1.9) 57 (3.0) 114 (1.6) 33.3 (26.4–41.0) 1.64 (1.32–2.03)
    Indigenous 492 (5.4) 132 (7.1) 360 (5.0) 26.8 (23.0–31.0) 1.33 (1.14–1.54)
    Latin-American 334 (3.7) 127 (6.8) 207 (2.9) 38.0 (32.8–43.5) 1.91 (1.65–2.20)
    South Asian 196 (2.2) 64 (3.4) 132 (1.8) 32.7 (26.2–39.8) 1.61 (1.31–1.97)
    Southeast Asian 179 (2.0) 48 (2.6) 131 (1.8) 26.8 (20.6–34.0) 1.31 (1.03–1.68)
    White 7650 (84.3) 1419 (75.9) 6231 (86.4) 18.5 (17.7–19.4) 0.59 (0.54–0.64)
Educational attainment
    < College/university degree 2046 (23.3) 478 (26.5) 1568 (22.4) 23.4 (21.6–25.3) 1.19 (1.08–1.30)
    College/university degree 6745 (76.7) 1326 (73.5) 5419 (77.6) 19.7 (18.7–20.6) Referent
Personal income
    < $30,000 2732 (33.8) 738 (43.5) 1994 (31.2) 27.0 (25.4–28.7) 1.66 (1.49–1.84)
    $30,000 to $59,999 2499 (30.9) 490 (28.9) 2009 (31.4) 19.6 (18.1–21.2) 1.20 (1.07–1.35)
    ≥ $60,000 2862 (35.4) 467 (27.6) 2395 (37.4) 16.3 (15.0–17.7) Referent
Area of residence
    Rural 422 (4.8) 81 (4.5) 341 (4.9) 19.2 (15.6–23.3) 0.94 (0.77–1.15)
    Suburban 2293 (26.0) 482 (26.6) 1811 (25.8) 21.0 (19.4–22.8) 1.03 (0.94–1.13)
    Urban 6121 (69.3) 4871 (69.4) 1250 (68.9) 20.4 (19.4–21.5) Referent
Immigration status
    Immigrant 1488 (16.3) 431 (23.1) 1057 (14.6) 29.0 (26.7–31.4) 1.53 (1.40–1.68)
    Canadian-born 7613 (83.7) 1438 (76.9) 6175 (85.4) 18.9 (18.0–19.8) Referent
Province/Territory
    British Columbia 1630 (17.8) 386 (20.5) 1244 (17.1) 23.7 (21.7–25.8) Referent
    Alberta 1371 (15.0) 304 (16.1) 1067 (14.7) 22.2 (20.0–24.5) 0.94 (0.82–1.07)
    Saskatchewan 239 (2.6) 42 (2.2) 197 (2.7) 17.6 (13.1–23.1) 0.74 (0.56–0.99)
    Manitoba 285 (3.1) 76 (4.0) 209 (2.9) 26.7 (21.7–32.3) 1.13 (0.91–1.39)
    Ontario 2787 (30.5) 620 (32.9) 2167 (29.8) 22.2 (20.7–23.8) 0.94 (0.84–1.05)
    Quebec 2016 (22.0) 288 (15.3) 1728 (23.8) 14.3 (12.8–15.9) 0.60 (0.53–0.69)
    Newfoundland & Labrador 153 (1.7) 33 (1.8) 120 (1.7) 21.6 (15.5–29.1) 0.91 (0.67–1.25)
    New Brunswick 162 (1.8) 31 (1.6) 131 (1.8) 19.1 (13.6–26.2) 0.81 (0.58–1.12)
    Nova Scotia 422 (4.6) 81 (4.3) 341 (4.7) 19.2 (15.6–23.3) 0.81 (0.65–1.00)
    Prince Edward Island 44 (0.5) 9 (0.5) 35 (0.5) 20.5 (10.3–35.8) 0.86 (0.48–1.56)
    Yukon 24 (0.3) 7 (0.4) 17 (0.2) 29.2 (13.4–51.2) 1.23 (0.66–2.31)
    Northwest Territories 8 (0.1) 3 (0.2) 5 (0.1) 37.5 (10.2–74.1) 1.58 (0.64–3.89)
    Nunavut 11 (0.1) 4 (0.2) 7 (0.1) 36.4 (12.4–68.4) 1.54 (0.70–3.37)

Note: N = 9,152; CI, confidence interval; RR, relative risk comparing prevalence of SOGIECE exposure to that of referent group; SN2019, Sex Now 2019.

a Missing, poor data quality, and “prefer not to answer” responses removed when applicable

b Percentage calculated using column total as denominator.

c Percentage calculated using row total as denominator.

d Responses allowed multiple-answers, overlap in responses.

Multivariable associations between socio-demographic characteristics and CTP and SOGIECE exposure

aRRs estimating associations between CTP exposure and socio-demographic characteristics were generally similar to crude RRs in magnitude, direction, and statistical significance, except in the case of age. The aRR for those <20 years of age decreased and was no longer statistically significant (aRR = 0.71, 95% CI 0.46, 1.10 cf. crude RR = 1.44, 95% CI 1.03, 2.03), while the aRR for those 20–29 years of age decreased and became statistically significant (aRR = 0.69, 95% CI 0.52, 0.90 cf. crude RR = 1.13, 95% CI 0.88, 1.43) (Table 3 cf. Table 1). aRRs estimating associations between SOGIECE exposure and socio-demographic characteristics were also generally similar to crude RRs in magnitude, direction, and statistical significance, except in the cases of sexual orientation, gender identity and income. The aRR for gay respondents increased and became statistically singificant (aRR = 1.21, 95% CI 1.08, 1.36 cf. crude RR = 1.05, 95% CI 0.95, 1.15). The aRR for non-binary and other gender identities both decreased and were no longer statistically significant (non-binary aRR = 1.07, 95% CI 0.91, 1.25 cf. crude RR = 2.47, 95% CI 2.17, 2.80; other aRR = 0.91, 95% CI 0.65, 1.27 cf. crude RR = 1.90, 95% CI 1.40, 2.58). Finally, the aRR for income $30,000 to $59,999 also decreased and was no longer statistically signficiant (aRR = 1.09, 95% CI 0.97, 1.23 cf. crude RR = 1.20, 95% CI 1.07, 1.35). (Table 3 cf. Table 2).

Table 3. Multivariable-adjusted associations between sociodemographic characteristics and exposure to conversion therapy or Sexual Orientation and Gender Identity Change Efforts (SOGIECE), among sexual and gender minority Canadian men, 2019.

Variable Conversion Therapy aRR (95% CI) SOGIECE aRR (95% CI)
Sexual identity
    Gay 1.34 (1.10, 1.62) 1.21 (1.08, 1.36)
    Other Referent Referent
Gender identity
    Non-binary 1.39 (1.01, 1.92) 1.07 (0.91, 1.26)
    Other 0.89 (0.47, 1.70) 0.91 (0.65, 1.27)
    Male Referent Referent
Transgender status
    Transgender 2.07 (1.64, 2.60) 2.72 (2.41, 3.07)
    Cisgender Referent Referent
Age (at time of survey)
    < 20 0.71 (0.46, 1.10) 2.09 (1.59, 2.74)
    20–29 0.69 (0.52, 0.90) 1.57 (1.26, 1.96)
    30–39 0.86 (0.66, 1.13) 1.35 (1.08, 1.69)
    40–49 1.00 (0.75, 1.33) 1.39 (1.10, 1.76)
    50–59 0.96 (0.72, 1.27) 1.31 (1.03, 1.66)
    60+ Referent Referent
“Out” about sexuality
    Out 1.34 (1.11, 1.63) 1.35 (1.20, 1.51)
    Not out Referent Referent
Race/Ethnicitya
    Indigenous 1.33 (1.03, 1.73) 1.20 (1.02, 1.41)
    POC 1.64 (1.33, 2.03) 1.64 (1.44, 1.87)
    White Referent Referent
Educational attainment
    < College/university degree 0.97 (0.82, 1.14) 1.00 (0.90, 1.11)
    College/university degree Referent Referent
Personal income, CAD
    < $30,000 1.99 (1.65, 2.39) 1.19 (1.05, 1.34)
    $30,000 to $59,999 1.36 (1.12, 1.64) 1.09 (0.97, 1.23)
    ≥ $60,000 Referent Referent
Area of residence
    Rural 1.29 (0.95, 1.75) 1.08 (0.87, 1.33)
    Suburban 1.14 (0.97, 1.34) 1.03 (0.93, 1.13)
    Urban Referent Referent
Immigration status
    Immigrant 1.28 (1.13, 1.68) 1.28 (1.13, 1.46)
    Canadian-born Referent Referent

Note: N = 9,214; CI, confidence interval; aRR, adjusted relative risk comparing prevalence of conversion therapy or sexual orientation and gender identity change efforts (SOGIECE) exposure to that of referent group (adjusted for all variables shown in table); SN2019, Sex Now 2019.

a Participants were given the option to select multiple racial/ethnic identities; owing to collinearity, identities were categorized as follows for multivariable modeling: Indigenous = any Indigenous identity, including those who are Indigenous and identified with another ethnic/racial category; People of colour (POC) = any identity other than Indigenous and white, including those who are POC and identified with the white category (i.e., multiethnic/multiracial respondents).

Details of CTP experiences

Among the 910 participants who were exposed to CTP, 77.3% reported that CTP exclusively targeted their sexual orientation, 5.9% reported that it exclusively targeted their gender identity, and 16.8% reported that it targeted both (Table 4). Most (67%) experienced CTP in a religious setting (faith-based organization, individual religious leader, or other religious individual), 30.3% with a licensed HCP, and 20.3% with an unlicensed HCP. Additionally, 72.0% initiated CTP before the age of 20 years. Duration and frequency of CTP ranged widely, with 23.8% attending for longer than 1 year and 30.9% attending more than five sessions. Duration and frequency of CTP did not differ by sexual orientation; however, more transgender participants (31.2%) than cisgender particiapnts (22.2%) reported attending CTP for >1 year (p<0.05), and more transgender particiapnts (39.2%) than cisgender participants (28.8%) reported attending CTP >5 times (p<0.05).

Table 4. Characteristics of conversion therapy among sexual and gender minority Canadian men, 2019.

Variable n (%)a (N = 910)
CTP exclusively targeting sexual orientation 564 (77.3)
CTP exclusively targeting gender identity 43 (5.9)
CTP targeting both sexual orientation and gender identity 123 (16.8)
Conversion therapy viab
    Licensed HCP 276 (30.3)
    Unlicensed HCP 185 (20.3)
    Camp 73 (8.0)
    Faith-based organization 218 (24.0)
    Individual religious leader 334 (36.7)
    Religious individual 383 (42.1)
    Other 169 (18.6)
Age at first conversion effort
    < 20 525 (72.0)
    20–29 149 (20.4)
    30–39 40 (5.5)
    40–49 8 (1.1)
    50–59 7 (1.0)
    60+ 0 (0.0)
Duration of conversion effort
    < 1 month 381 (49.5)
    1 month– 1 year 205 (26.7)
    > 1 year 183 (23.8)
Conversion effort attempts
    1 time only 269 (34.9)
    2–5 times 264 (34.2)
    > 5 times 238 (30.9)

Note: N = 910; CTP, conversion therapy practices; HCP, health care practitioner.

a Missing response removed when applicable. Percentage calculated using column total as denominator.

b Responses allowed multiple-answers, overlap in responses.

Psychosocial health outcomes and social and professional support access

Relative to those not exposed to CTP, those exposed reported greater experiences of isolation and feeling left out (Table 5). Involvement with GBQ community, connection to GBQ community, and mental health service access were also more common among those exposed to CTP as compared with those not exposed. Direction and statistical significance of comparisons in psychosocial outcomes were similar for SOGIECE exposure, with the addition of other substance use, which was more common among those exposed to SOGIECE than among those not exposed (Table 6).

Table 5. Psychosocial health outcomes and social and professional support access associated with exposure to conversion therapy among sexual and gender minority Canadian men.

Variable n (%) among those Exposed to CTPa (n = 910) n (%) among Those Not Exposed to CTPa (n = 8304) RR (95% CI)
Psychosocial health outcomes
    Isolated some or all of time 495 (73.8) 3723 (61.5) 1.67 (1.42–1.97)
    Left out some or all of time 502 (74.8) 3846 (63.4) 1.63 (1.38–1.93)
    Any binge alcohol use, past 6 months 363 (53.0) 3457 (55.8) 0.90 (0.78–1.04)
    Any other substance use, past 6 monthsb 184 (26.9) 1491 (24.1) 1.14 (0.97–1.34)
Social and professional supports
    Involved with GBQ community 214 (32.3) 1132 (19.1) 1.86 (1.60–2.17)
    Connected to GBQ community 247 (36.9) 1888 (31.3) 1.25 (1.08–1.45)
    Accessed mental health servicesc 380 (57.4) 2112 (35.3) 2.16 (1.87–2.50)

Note: N = 9,214; CI, confidence interval; RR, relative risk comparing prevalence of conversion therapy exposure to that of referent group; CTP, conversion therapy; GBQ, gay, bi, and/or queer.

a Missing, poor data quality, and “prefer not to answer” responses removed when applicable. Percentage calculated using column total as denominator.

b Benzodiazepines, cocaine, crack, crystal, ecstasy, fentanyl, γ-hydroxybutyrate (GHB), heroin, ketamine, other opioids, psychedelics.

c In the past year.

Table 6. Psychosocial health outcomes and social and professional support access associated with exposure to Sexual Orientation and Gender Identity Change Efforts (SOGIECE) among sexual minority Canadian men.

Variable n (%) among those Exposed to SOGIECEa (n = 1884) n (%) among Those Not Exposed to SOGIECEa (n = 7268) RR (95% CI)
Psychosocial health outcomes
    Isolated some or all of time 1047 (72.9) 3155 (59.9) 1.60 (1.44–1.78)
    Left out some or all of time 1062 (74.0) 3270 (62.0) 1.56 (1.40–1.74)
    Any binge alcohol use, past 6 months 841 (57.4) 2969 (55.2) 1.07 (0.98–1.18)
    Any other substance use, past 6 monthsb 403 (27.5) 1265 (23.5) 1.18 (1.06–1.30)
Social and professional supports
    Involved with GBQ community 436 (31.0) 902 (17.5) 1.76 (1.60–1.93)
    Connected to GBQ community 500 (34.9) 1630 (31.1) 1.15 (1.04–1.26)
    Accessed mental health servicesc 721 (50.1) 1759 (33.8) 1.68 (1.54–1.84)

Note: N = 9,152; CI, confidence interval; RR, relative risk comparing prevalence of SOGIECE exposure to that of referent group; GBQ, gay, bi, and/or queer.

a Missing, poor data quality, and “prefer not to answer” responses removed when applicable. Percentage calculated using column total as denominator.

b Benzodiazepines, cocaine, crack, crystal, ecstasy, fentanyl, γ-hydroxybutyrate (GHB), heroin, ketamine, other opioids, psychedelics.

c In the past year.

Discussion

This study demonstrates that 1 in 10 sexual minority men non-randomly sampled in a Canadian community-based survey have experienced conversion therapy practices. Assuming that 4% of Canadian men are sexual minorities [27, 28], this corresponds to more than 50,000 adult men in Canada. As with previous surveys in Canada [8], we found that experiences of CTP were more prevalent among the youngest survey participants (i.e., 13% among those <20 years of age versus 9% among those 60+ years of age), despite these men having come of age during a time when visibility and social acceptance of minority sexual orientations are greater than they were for previous generations [29]. This paradoxical finding may be partially explained by a ‘developmental collision’, in which younger generations are coming out earlier, thereby increasing the period of potential exposure to CTP [30]. We found some support for this hypothesis in multivariable analyses, which reduced or reversed the aRR for the youngest age groups, with adjustment for a variety of covarying factors, including ‘outness’ (Table 3). Regardless of the reasons, the high prevalence of CTP among those <20 years of age suggests that existing measures to curtail CTP—such as the numerous statements issued by health professionals in opposition to CTP [1]—are insufficient.

Our CTP prevalence estimate is greater than that derived from the 2011–12 iteration of our survey (3.5%) but comparable with more recent US estimates (8–18%) [8, 17, 18]. There are several reasons to regard the 2019–20 estimate as a more valid reflection of the true prevalence of CTP among sexual minority men in Canada. First, in the 2011–12 survey, CTP was narrowly defined as “sexual repair/reorientation counseling”, whereas in the 2019–20 survey, we used a broader definition of “attempts to change sexual orientation or gender identity [including] more organized activities (such as counseling or faith-based rituals) that are sometimes referred to as ‘conversion therapy’”, which is consistent with US survey measures and international definitions of contemporary CTP [7, 17, 18, 31]. Second, the 2019–20 survey is more recent and thus may reflect any temporal changes in CTP experiences. Third, we included and identified 9% of the 2019–20 sample as transgender and included measures of CTP targeting gender identity, allowing us to more fully capture ongoing and prevalent transgender CTP.

This is the first study (to our knowledge) to describe detailed characteristics of CTP in a large sample. Most importantly, we found that there is not a single setting where CTP occurs. Rather, these practices occur in licensed and unlicensed healthcare provider offices, camps, and organized religious settings, as well as in individual consultation with religious leaders and other religious individuals. This finding affirms the need for a multi-pronged strategy to address CTP, which may include social and therapeutic (counseling, support groups, etc.) supports for those who have experienced trauma due to CTP, legislative bans, institutional policies that create sexual and gender minority-affirming healthcare and religious environments, and communications strategies that inform youths and their families that CTP is harmful and unwarranted for those struggling with matters of sexual orientation and/or gender identity and/or expression [12].

Exposure to CTP is not evenly distributed within the population of sexual and gender minority men in Canada. Rather, experiences of CTP were more common among those with lower current levels of personal income, non-binary and transgender people, and many racialized minorities, including African, Arab, Black, Carribbean, Indigenous, Latin American, and South Asian individuals. The implications of these social inequities in CTP experience are dire and must be addressed. In the case of transgender people, new laws, policies, and interventions must be inclusive of the forms of CTP that trans people experience; unlike CTP targeting sexual orientation, most CTP targeting gender identity and expression continues to occur in licensed healthcare settings, when transgender individuals are seeking access to gate-kept gender-affirming care [1, 4, 10, 15, 32, 33]. As currently written, federal Bill C-6 excludes forms of CTP at the hands of a practitioner who argues that they do not intend to “change a person’s… gender identity” but whose goal is nevertheless to discourage or delay the adoption of gender identities not assigned at birth, as well as non-conforming gender expressions [5].

In the case of racial, ethnic, and immigrant disparities in CTP experience, we must work with racialized and immigrant communities to understand how CTP is presented in cross-cultural contexts. For example, researchers and sexual and gender minority-affirming organizations may undertake an in-depth examination of how LGBTQ2-affirming policies differentially reaches families and youth of colour [3437]. In addition, reviews of the recent international growth of CTP point to a mechanism whereby a sizeable number sexual and gender minority immigrants may be arriving to Canada from countries where levels of sexual and gender minority stigma, and in some cases criminalization, are high, and therefore from contexts where CTP is even more common than it is in Canada [38]. Further research exploring the intersection of ethnoracial identity and immigration status in relation to CTP may help to interpret these findings. Given the overrepresentation of people of colour among those who have endured CTP, we suggest provision of CTP support services that are focused on the needs of racialized CTP survivors. We additionally acknowledge that SOGIECE was, in concept, a component of the residential schools used to strip Indigenous people of their culture; as Sarah Hunt notes, “residential schools racialized native children as ‘Indians’ while enforcing strict divisions between girls and boys through European dress and hairstyles, as well as physically separating them in different dorms”, thereby contravening pre-colonial non-binary gender identities and roles, now referred to as Two-Spirit [14, 39]. It may be the case that one of the lasting effects of colonialism and Christianity imposed upon Indigenous peoples includes greater exposure to CTP; regardless, more work is needed to understand this critical inequity.

Limitations

Our sample largely came from social media or dating applications and thus constitutes a non-probabilistic subset of the total target population. We have previously demonstrated that non-probability surveys tend to overrepresent employed, high-income-earning, and gay-identified sexual minorities [40]. Given that income is inversely associated with CTP exposure, in our data, this suggests that we may have underestimated the lifetime prevalence of CTP among sexual minority men in Canada. While the measure of CTP we used was more sensitive than that in the 2011–12 survey, CTP remains poorly understood, and often vaguely defined [2]. Thus, we likely undercounted some experiences of CTP, and this is an additional reason to expect that 10% is an underestimate of the true prevalence of CTP. By design, Sex Now does not include sexual minority women; data from the US, however, have shown comparably high rates of CTP among lesbian, bisexual, and queer women (personal communication, Christy Mallory, April 24, 2020) [18]. On this basis, we recommend that any and all proposed laws, policies, and interventions to address CTP in Canada be made gender-inclusive. While we explored a broad array of social determinants of CTP experience, we did not measure religiosity or religious affiliation/identity, which may further explain some of the variability of CTP in our sample. Finally, we used a lifetime exposure measure in this survey; therefore, we cannot know how long ago CTP occurred. The inverse relationship between age and CTP exposure suggests that contemporary CTP remains prevalent; nonetheless, additional data to account for recency of CTP are needed.

Conclusion

Given that over 50,000 people in Canada have experienced CTP, we recommend the following actions, in collaboration with multiple levels of government, CTP survivors, and community organizations. First, given the disproportionate burden of CTP among non-binary and trans participants in our study, legislation addressing CTP should be reviewed to ensure that it is inclusive of transgender and gender identity-based CTP. Second, given the large burden of psychosocial problems associated with CTP experience, we recommend the initiation of sexual and gender minority-affirming social and mental health supports for those who experienced trauma through CTP. The large burden of CTP we have measured in a population of sexual and gender minority men in Canada suggests that historic trauma caused by CTP will require ongoing support, over multiple generations. Finally, all people in Canada, and especially those working with youth, have a fundamental role to play in clearly and consistently communicating that lesbian, gay, bisexual, transgender, queer, and Two-Spirit experiences and identities are valued and compatible with happy and healthy lives. Only once this message is confidently and equitably expressed to youths will CTP and its counterparts in the form of SOGIECE be fully eradicated for new generations.

Data Availability

Partial Sex Now data is publicly available on the Our Stats dashboard (https://ourstats.ca/our-dashboard). The University of Victoria’s Human Research Ethics Board has only approved storage of our data on secure university servers since the data contain potentially sensitive information about study participants. Data is available on request through secure university servers only. Any requests to access the data can be made to University of Victoria’s Human Research Ethics Board (250-472-4545 or ethics@uvic.ca; reference Ethics Protocol Number BC17-487).

Funding Statement

Analyses of secondary data (SexNow) were funded by the Canadian Institutes of Health Research (#168193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

Decision Letter 0

Xiaozhao Yousef Yang

24 Feb 2021

PONE-D-20-38781

Experiences with sexual orientation and gender identity conversion therapy practices among sexual minority men in Canada, 2019-2020

PLOS ONE

Dear Dr. Salway,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 10 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Xiaozhao Yousef Yang

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Overall, the authors explored an interesting subject which has great implications to policymaking. The organization and presentation of the manuscript are very clear. Below I listed my questions and comments for the authors.

1. I would like to see more discussions about the two previous research on CTP based in Canada. Information such as how samples were collected, sample sizes, mean age of respondents, and geographic locations of the respondents if such information is available.

2. In the introduction section, the authors may also want to briefly explain why some of their focuses matter—settings of CTP occurrence, age at initiation of CTP etc. Are variations in those variables associated with variations in risks for feelings of shame, anxiety, depression, problematic substance use, suicide ideation, and/or suicide attempts—those consequences mentioned in the first paragraph? Some more discussion on this question may better highlight the importance and contribution that this study may potentially make.

3. “In total, N=7,237 provided a response to the last question”. Does it mean that 7,237 respondents answered the very last question or all questions? If it is the former, then what is the last question? Why is the very last question so important that it is worth mentioning here?

4. In the primary outcome variable, what are those response categories?

5. “Analyses were descriptive (univariate) and bivariate; multivariable analyses were not consistent with the objectives of this study, i.e., to generate statistics that inform CTP policy and intervention, rather than to identify causal effects (i.e., controlling for relationships between covariates)”. Your data are not longitudinal and therefore even if you use multivariate analysis, the results cannot reveal causality. On the other hand, why can’t multivariate analyses be used for policy making purposes? Isn’t multivariate analysis more capable of providing evidence of robust relationship than a bivariate analysis?

6. “This study demonstrates that 1 in 10 sexual minority men in Canada have experienced conversion therapy practices”. This is a very bold statement as your sample may not be nationally representative.

7. “We found that experiences of CTP were more prevalent among the youngest survey participants, despite these men having come of age during a time when visibility and social acceptance of minority sexual orientations is greater than it was for previous generations”. Could it also be that because of the greater social acceptance in recent years, the younger are more likely to come out and thus make themselves an easier target for CTP? This is why I think multivariate analyses can do a better job on informing the public and policymakers about the actual correlates of the outcome variable of interest.

8. Reading table 1 and 2, the 95% C.I. s are fine but should caution the readers that interpreting those statistics should be based on the assumption that the sample is representative of the population of interest but the samples used in the study are not. The authors may want to raise this issue in the results section.

9. As for table 3, I was wondering does “duration of conversion effort” or “conversion effort attempts” vary by sexual and gender identity?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 3;16(6):e0252539. doi: 10.1371/journal.pone.0252539.r002

Author response to Decision Letter 0


19 Apr 2021

April 10, 2021

Dear Dr. Yang,

On behalf of named co-authors, I am pleased to submit a revised manuscript, in which we attend to the helpful comments from you and the reviewer, as outlined below.

We look forward to hearing from you about next steps.

Sincerely,

Travis Salway, travis_salway@sfu.ca

Editor comments:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: Thank you. We have adjusted the formatting of the manuscript to correspond to the PLoS ONE style requirements outlined in these links. We were unable to find instructions for file naming, but have replaced each file name with the first author’s last name + “Revised manuscript marked”, “Revised manuscript clean”, and “Response to reviewers.”

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

Response: We have added this detail to the manuscript (p7, lines 137-138).

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions .

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Response: We have revised the ‘Data Availability’ statement as follows: “The University of Victoria's Human Research Ethics Board has only approved storage of our data on secure university servers because the data contain potentially sensitive information about study participants. Data are available upon request through secure university servers only. Any requests to access the data can be made to University of Victoria's Human Research Ethics Board (250-472-4545 or ethics@uvic.ca). For further information about SexNow data access, including aggregated survey statistics, visit: https://www.cbrc.net/ourstats”

Reviewer comments:

Reviewer #1: Overall, the authors explored an interesting subject which has great implications to policymaking. The organization and presentation of the manuscript are very clear. Below I listed my questions and comments for the authors.

1. I would like to see more discussions about the two previous research on CTP based in Canada. Information such as how samples were collected, sample sizes, mean age of respondents, and geographic locations of the respondents if such information is available.

Response: We have added these details about SexNow 2011 and TransPulse 2019 to the Introduction (p4, lines 80-83).

2. In the introduction section, the authors may also want to briefly explain why some of their focuses matter—settings of CTP occurrence, age at initiation of CTP etc. Are variations in those variables associated with variations in risks for feelings of shame, anxiety, depression, problematic substance use, suicide ideation, and/or suicide attempts—those consequences mentioned in the first paragraph? Some more discussion on this question may better highlight the importance and contribution that this study may potentially make.

Response: Thank you for pointing out this gap in our rationale. Empirical data regarding these parameters are important when designing legislative approaches (e.g., bans) or educational campaigns to prevent CTP exposure. We have added this explanation to the corresponding section of the Introduction (pp4-5, lines 89-92).

3. “In total, N=7,237 provided a response to the last question”. Does it mean that 7,237 respondents answered the very last question or all questions? If it is the former, then what is the last question? Why is the very last question so important that it is worth mentioning here?

Response: This means that 7,237 respondents completed the entire survey, although some may have skipped questions along the way. We have revised this sentence for clarity (p7, line 140). We believe this detail is useful for readers interested in knowing the number of participants who stopped answering survey the survey between the first and last question.

4. In the primary outcome variable, what are those response categories?

Response: We have added the response categories to this part of the Methods section, for further clarity (p7, lines 145-149).

5. “Analyses were descriptive (univariate) and bivariate; multivariable analyses were not consistent with the objectives of this study, i.e., to generate statistics that inform CTP policy and intervention, rather than to identify causal effects (i.e., controlling for relationships between covariates)”. Your data are not longitudinal and therefore even if you use multivariate analysis, the results cannot reveal causality. On the other hand, why can’t multivariate analyses be used for policy making purposes? Isn’t multivariate analysis more capable of providing evidence of robust relationship than a bivariate analysis?

Response: Thank you for this suggestion. We have now analyzed multivariable models for both of the outcomes and added these results to a new table (now labeled Table 3). Corresponding methods statements have been added (p10, lines 206-210), and the multivariable/adjusted relative risks are interpreted in a new sub-section of Results (pp11-12, lines 237-254).

6. “This study demonstrates that 1 in 10 sexual minority men in Canada have experienced conversion therapy practices”. This is a very bold statement as your sample may not be nationally representative.

Response: We agree that this estimate should be interpreted with caution, given the non-probabilistic sampling methods used. We have revised this sentence (p13, lines 280-281) as follows: “This study demonstrates that 1 in 10 sexual minority men non-randomly sampled in a Canadian community-based survey have experienced conversion therapy practices.”

7. “We found that experiences of CTP were more prevalent among the youngest survey participants, despite these men having come of age during a time when visibility and social acceptance of minority sexual orientations is greater than it was for previous generations”. Could it also be that because of the greater social acceptance in recent years, the younger are more likely to come out and thus make themselves an easier target for CTP? This is why I think multivariate analyses can do a better job on informing the public and policymakers about the actual correlates of the outcome variable of interest.

Response: Thank you for this suggestion. We agree that this is a convincing explanation for the greater prevalence of CTP in the youngest age group, and we have added this suggested interpretation to the Discussion section (p13, lines 287-292), including an acknowledgment that the association between young age and CTP exposure was reduced with adjustment, notably including adjustment for outness.

8. Reading table 1 and 2, the 95% C.I. s are fine but should caution the readers that interpreting those statistics should be based on the assumption that the sample is representative of the population of interest but the samples used in the study are not. The authors may want to raise this issue in the results section.

Response: We have added a statement acknowledging that our sample does not meet the assumption of randomness and CIs should therefore be interpreted with caution (p9, lines 194-196).

9. As for table 3, I was wondering does “duration of conversion effort” or “conversion effort attempts” vary by sexual and gender identity?

Response: Thank you for this suggestion. We have analyzed these two variables by sexual orientation and gender identity and added the results to the corresponding section of the manuscript (p12, lines 264-267).

Attachment

Submitted filename: Salway_ResponseToReviewers_20210410.docx

Decision Letter 1

Xiaozhao Yousef Yang

18 May 2021

Experiences with sexual orientation and gender identity conversion therapy practices among sexual minority men in Canada, 2019-2020

PONE-D-20-38781R1

Dear Dr. Salway,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Xiaozhao Yousef Yang, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Xiaozhao Yousef Yang

24 May 2021

PONE-D-20-38781R1

Experiences with sexual orientation and gender identity conversion therapy practices among sexual minority men in Canada, 2019-2020

Dear Dr. Salway:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Xiaozhao Yousef Yang

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Salway_ResponseToReviewers_20210410.docx

    Data Availability Statement

    Partial Sex Now data is publicly available on the Our Stats dashboard (https://ourstats.ca/our-dashboard). The University of Victoria’s Human Research Ethics Board has only approved storage of our data on secure university servers since the data contain potentially sensitive information about study participants. Data is available on request through secure university servers only. Any requests to access the data can be made to University of Victoria’s Human Research Ethics Board (250-472-4545 or ethics@uvic.ca; reference Ethics Protocol Number BC17-487).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES